Dosage affects bleeding outcomes in edoxaban patients with creatinine clearance levels near the dose-adjustment threshold: a subanalysis of the ENVISAGE-TAVI AF trial
MEHRAN R. (1), VAN MIEGHEM N. (2), UNVERDORBEN M. (3), HENGSTENBERG C. (4), VRANCKX P. (5), MORENO R. (6), VALGIMIGLI M. (7), JIN J. (3), VELTKAMP R. (8), DANGAS G. (1)
(1) Mount Sinai Medical Center, NY UNITED STATES
(2) Erasmus MC, Rotterdam NETHERLANDS
(3) Daiichi Sankyo, Inc., NJ UNITED STATES
(4) Medical University of Vienna, Vienna AUSTRIA
(5) Jessa Hospital, Hasselt BELGIUM
(6) Hospital Universitario La Paz, Madrid SPAIN
(7) University of Italian Switzerland, Lugano SWITZERLAND
(8) Imperial College London, London UNITED KINGDOM